Mesoporous organosilica nanoparticles: Degradation strategies and application in tumor therapy

Abstract

Biodegradation is a crucial issue for silica-based mesoporous nanoparticles that is related to the biosafety in tumor therapy. Nowadays, mesoporous silica nanoparticles (MSNs) have been intensively developed to construct multifunctional nanosystems for tumor therapy due to their biocompatibility, high drug loading capacity and easy functionalization; however, their biodegradation is relatively slow and still under debate. To improve the biodegradability of silica-based mesoporous nanoparticles, a simple organic-inorganic hybridization strategy to synthesize mesoporous organosilica nanoparticles (MONs) has been successfully developed. By hybridizing the silica framework (-Si-O-Si-) with stimuli-sensitive organic moieties to form organic-inorganic network (-Si-R-Si-, R: organic moiety), when exposed to the stimuli environment, the breakdown of the organic-inorganic network could accelerate the degradation of MONs, which is great promising for MONs as a multifunctional therapeutic nanoplatform in tumor therapy. This review aims to summarize the degradation strategies for MONs to improve biodegradability in recent years, and highlight the potential applications of MONs in tumor therapy. Finally, we also discuss the challenges of MONs for tumor therapy in future clinical translation.

Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials

“…Owing to the inherently high surface area, tailorable surface property, and preferable biocompatibility, mesoporous silica nanoparticles are ideal candidates for drug delivery and cancer chemo-immunotherapy. [148,149] The combination of immunogenic chemotherapeutics with ICIs in mesoporous silica nanoparticles has exhibited a strong immune stimulation capacity for cancer chemo-immunotherapy through simultaneously Reproduced with permission. [155] Copyright 2023, Wiley-VCH.…”

Sm/Co‐Doped Silica‐Based Nanozymes Reprogram Tumor Microenvironment for ATP‐Inhibited Tumor Therapy

“…[51,52] Surprisingly, mesoporous silica (mSiO 2 ) with diverse porous structure and high specific surface areas can be used to synthesize and immobilize metallic ions by entrapment, cross-linking, physical adsorption, and covalent binding techniques. [53] Specific nanometric size is required to generate fitted magnetic and catalysis properties, making it applicable for high-temperature solvent pyrolysis. Therefore, an appropriate enzymatic effects can be customized with a high-temperature solvent pyrolysis method and proportion controlment of variable valence metals dope on mSiO 2 .…”

Modulation of hypoxia and redox in the solid tumor microenvironment with a catalytic nanoplatform to enhance combinational chemodynamic/sonodynamic therapy

“…1 They play essential roles in physiological functions, hormone production, inflammation mediation, cell signaling regulation, protein modulation, and pathogen elimination. However, excessively high levels of intracellular ROS can cause severe damage to proteins, lipids, and DNA without specificity, 2 and thus ROS-based cancer therapies, 3 including chemodynamic therapy (CDT), [4][5][6] sonodynamic therapy (SDT), 7,8 and photodynamic therapy (PDT), 9,10 have been evidenced to eradicate cancer cells and have been extensively explored in past years. Despite their minimal invasiveness and high specificity to the tumors, the therapeutic effects are still restrained by the complicated tumor microenvironment (TME).…”